135 related articles for article (PubMed ID: 22546548)
41. Cholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosis.
Murphy AJ; Dragoljevic D; Tall AR
Front Immunol; 2014; 5():490. PubMed ID: 25352845
[TBL] [Abstract][Full Text] [Related]
42. Unorthodox Transcriptional Mechanisms of Lipid-Sensing Nuclear Receptors in Macrophages: Are We Opening a New Chapter?
Czimmerer Z; Halasz L; Nagy L
Front Endocrinol (Lausanne); 2020; 11():609099. PubMed ID: 33362723
[TBL] [Abstract][Full Text] [Related]
43. IRF2BP2: A New Player at the Crossroads of Inflammation and Lipid Metabolism.
Zhang H; Reilly MP
Circ Res; 2015 Sep; 117(8):656-8. PubMed ID: 26405180
[No Abstract] [Full Text] [Related]
44. [Nuclear receptors and renal water transport regulation].
Wang B; Zhang XY
Sheng Li Xue Bao; 2018 Dec; 70(6):630-638. PubMed ID: 30560272
[TBL] [Abstract][Full Text] [Related]
45. Nuclear receptors in vascular biology.
Bishop-Bailey D
Curr Atheroscler Rep; 2015 May; 17(5):507. PubMed ID: 25772409
[TBL] [Abstract][Full Text] [Related]
46. Reprogramming cholesterol metabolism in macrophages and its role in host defense against cholesterol-dependent cytolysins.
Lee MS; Bensinger SJ
Cell Mol Immunol; 2022 Mar; 19(3):327-336. PubMed ID: 35017717
[TBL] [Abstract][Full Text] [Related]
47. Liver X Receptors as Therapeutic Targets for Managing Cholesterol: Implications for Atherosclerosis and Other Inflammatory Conditions.
Zhang Y; Chan JF; Cummins CL
Clin Lipidol; 2009 Feb; 4(1):29-40. PubMed ID: 20852746
[TBL] [Abstract][Full Text] [Related]
48. Cholesterol-receptor-mediated genomics in health and disease.
Kaul D
Trends Mol Med; 2003 Oct; 9(10):442-9. PubMed ID: 14557057
[TBL] [Abstract][Full Text] [Related]
49. Nuclear receptor control of opposing macrophage phenotypes in cardiovascular disease.
Frieler RA; Ramnarayanan S; Mortensen RM
Front Biosci (Landmark Ed); 2012 Jan; 17(5):1917-30. PubMed ID: 22201845
[TBL] [Abstract][Full Text] [Related]
50. [Biological function of endoecology (cleanliness of intercellular environment) realize two biolocical reactions: excretion reaction and inflammation reaction - utilization in vivo, in situ catabolites of the large molecular mass.].
Titov VN
Klin Lab Diagn; 2018; 63(11):668-676. PubMed ID: 30776199
[TBL] [Abstract][Full Text] [Related]
51. Molecular control of tissue-resident macrophage identity by nuclear receptors.
Porcuna J; Menéndez-Gutiérrez MP; Ricote M
Curr Opin Pharmacol; 2020 Aug; 53():27-34. PubMed ID: 32403022
[TBL] [Abstract][Full Text] [Related]
52. The effect of platelets on macrophage lipoprotein metabolism.
Aviram M
Atherosclerosis; 1988 Oct; 73(2-3):269-71. PubMed ID: 3190824
[No Abstract] [Full Text] [Related]
53. Macrophages in homeostatic immune function.
Jantsch J; Binger KJ; Müller DN; Titze J
Front Physiol; 2014; 5():146. PubMed ID: 24847274
[TBL] [Abstract][Full Text] [Related]
54. Crosstalk between reverse cholesterol transport and innate immunity.
Azzam KM; Fessler MB
Trends Endocrinol Metab; 2012 Apr; 23(4):169-78. PubMed ID: 22406271
[TBL] [Abstract][Full Text] [Related]
55. The Multifaceted Nature of Macrophages in Cardiovascular Disease.
Li CX; Yue L
Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927523
[TBL] [Abstract][Full Text] [Related]
56. Cholesterol Metabolism in T Cells.
Bietz A; Zhu H; Xue M; Xu C
Front Immunol; 2017; 8():1664. PubMed ID: 29230226
[TBL] [Abstract][Full Text] [Related]
57. Corrigendum to: Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism.
Cardiovasc Res; 2024 Jul; 120(8):971. PubMed ID: 38301662
[No Abstract] [Full Text] [Related]
58. Macrophages: Dissolving cholesterol to unclog arteries.
Leavy O
Nat Rev Immunol; 2016 Apr; 16(5):274-5. PubMed ID: 27121648
[No Abstract] [Full Text] [Related]
59. [The cholesterol metabolism in macrophages and its regulators].
Gong YN; Li FR; Yao WJ
Sheng Li Ke Xue Jin Zhan; 2016 Aug; 47(4):291-4. PubMed ID: 29889476
[No Abstract] [Full Text] [Related]
60. Oxidized Low-Density Lipoprotein Accumulation in Macrophages Impairs Lipopolysaccharide-Induced Activation of AKT2, ATP Citrate Lyase, Acetyl-Coenzyme A Production, and Inflammatory Gene H3K27 Acetylation.
Ting KKY; Yu P; Iyayi M; Dow R; Hyduk SJ; Floro E; Ibrahim H; Karim S; Polenz CK; Winer DA; Woo M; Rocheleau J; Jongstra-Bilen J; Cybulsky MI
Immunohorizons; 2024 Jan; 8(1):57-73. PubMed ID: 38193847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
